skip to main content
Idioma:
Mostrar Somente
Refinado por: assunto: Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use remover assunto: Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study
De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study
Material Type:
Artigo 		Adicionar ao Meu Espaço

De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study

Guarneri, V. ; Dieci, M.V. ; Bisagni, G. ; Frassoldati, A. ; Bianchi, G.V. ; De Salvo, G.L. ; Orvieto, E. ; Urso, L. ; Pascual, T. ; Paré, L. ; Galván, P. ; Ambroggi, M. ; Giorgi, C.A. ; Moretti, G. ; Griguolo, G. ; Vicini, R. ; Prat, A. ; Conte, P.F.

Annals of oncology, 2019-06, Vol.30 (6), p.921-926 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Prognostic Value of Pathologic Complete Response After Primary Chemotherapy in Relation to Hormone Receptor Status and Other Factors
Prognostic Value of Pathologic Complete Response After Primary Chemotherapy in Relation to Hormone Receptor Status and Other Factors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognostic Value of Pathologic Complete Response After Primary Chemotherapy in Relation to Hormone Receptor Status and Other Factors

GUARNERI, Valentina ; BROGLIO, Kristine ; GONZALEZ-ANGULO, Ana M ; KAU, Shu-Wan ; CRISTOFANILLI, Massimo ; BUZDAR, Aman U ; VALERO, Vicente ; BUCHHOLZ, Thomas ; MERIC, Funda ; MIDDLETON, Lavinia ; HORTOBAGYI, Gabriel N

Journal of clinical oncology, 2006-03, Vol.24 (7), p.1037-1044 [Periódico revisado por pares]

Baltimore, MD: American Society of Clinical Oncology

Sem texto completo

Citações Citado por
3
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study

Harbeck, N. ; Rastogi, P. ; Martin, M. ; Tolaney, S.M. ; Shao, Z.M. ; Fasching, P.A. ; Huang, C.S. ; Jaliffe, G.G. ; Tryakin, A. ; Goetz, M.P. ; Rugo, H.S. ; Senkus, E. ; Testa, L. ; Andersson, M. ; Tamura, K. ; Del Mastro, L. ; Steger, G.G. ; Kreipe, H. ; Hegg, R. ; Sohn, J. ; Guarneri, V. ; Cortés, J. ; Hamilton, E. ; André, V. ; Wei, R. ; Barriga, S. ; Sherwood, S. ; Forrester, T. ; Munoz, M. ; Shahir, A. ; San Antonio, B. ; Nabinger, S.C. ; Toi, M. ; Johnston, S.R.D. ; O’Shaughnessy, J. ; Jimenez, M.M. ; Johnston, S. ; Boyle, F. ; Steger, G.G. ; Neven, P. ; Jiang, Z. ; Campone, M. ; Huober, J. ; Shimizu, C. ; Cicin, I. ; Wardley, A. ; Tolaney, S.M. ; Abuin, G.G. ; Zarba, J. ; Lim, E. ; Sant, P. ; Liao, N. ; Christiansen, B. ; Eigeliene, N. ; Martin-Babau, J. ; Ettl, J. ; Mavroudis, D. ; Chiu, J. ; Boer, K. ; Nagarkar, R. ; Paluch-Shimon, S. ; Moscetti, L. ; Sagara, Y. ; Kim, S.-B. ; Maciel, M.M. ; Tjan-Heijnen, V. ; Broom, R. ; Lacko, A. ; Schenker, M. ; Volkov, N. ; Sim Yap, Y. ; Coccia-Portugal, M. ; Ángel García Sáenz, J. ; Andersson, A. ; Chao, T.-Y. ; Gokmen, E. ; Harputluoglu, H. ; Berzoy, O. ; Patt, D. ; McArthur, H. ; Chew, H. ; Chalasani, P. ; Kaufman, P. ; Tedesco, K. ; Graff, S.L.

Annals of oncology, 2021-12, Vol.32 (12), p.1571-1581 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer
Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer

Guarneri, Valentina ; Miles, David ; Robert, Nicholas ; Diéras, Véronique ; Glaspy, John ; Smith, Ian ; Thomssen, Christoph ; Biganzoli, Laura ; Taran, Tanya ; Conte, PierFranco

Breast cancer research and treatment, 2010-07, Vol.122 (1), p.181-188 [Periódico revisado por pares]

Boston: Boston : Springer US

Texto completo disponível

Citações Citado por
5
Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis
Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis

Marinovich, Michael L ; Macaskill, Petra ; Irwig, Les ; Sardanelli, Francesco ; Mamounas, Eleftherios ; von Minckwitz, Gunter ; Guarneri, Valentina ; Partridge, Savannah C ; Wright, Frances C ; Choi, Jae Hyuck ; Bhattacharyya, Madhumita ; Martincich, Laura ; Yeh, Eren ; Londero, Viviana ; Houssami, Nehmat

BMC cancer, 2015-10, Vol.15 (1), p.662-662, Article 662 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
6
T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational study
T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational study
Material Type:
Artigo 		Adicionar ao Meu Espaço

T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational study

Schettini, F. ; Conte, B. ; Buono, G. ; De Placido, P. ; Parola, S. ; Griguolo, G. ; Fabi, A. ; Bighin, C. ; Riccardi, F. ; Cianniello, D. ; De Laurentiis, M. ; Puglisi, F. ; Pelizzari, G. ; Bonotto, M. ; Russo, S. ; Frassoldati, A. ; Pazzola, A. ; Montemurro, F. ; Lambertini, M. ; Guarneri, V. ; Cognetti, F. ; Locci, M. ; Generali, D. ; Conte, P. ; De Placido, S. ; Giuliano, M. ; Arpino, G. ; Del Mastro, L.

ESMO open, 2021-04, Vol.6 (2), p.100099-100099, Article 100099 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Primary chemotherapy with gemcitabine, epirubicin and taxol (GET) in operable breast cancer: a phase II study
Primary chemotherapy with gemcitabine, epirubicin and taxol (GET) in operable breast cancer: a phase II study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Primary chemotherapy with gemcitabine, epirubicin and taxol (GET) in operable breast cancer: a phase II study

CONTE, P. F ; DONATI, S ; NACCARATO, A. G ; ESPOSTI, R. Degli ; BONARDI, S ; BOTTINI, A ; SARACCHINI, S ; TUMOLO, S ; GULLO, G ; SANTORO, A ; CRINO, L ; GENNARI, A ; GUARNERI, V ; ORLANDINI, C ; RONDINI, M ; RONCELLA, M ; MARINI, L ; COLLECCHI, P ; VIACAVA, P

British journal of cancer, 2005-08, Vol.93 (4), p.406-411 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
8
Accelerated-Intensified Cyclophosphamide, Epirubicin, and Fluorouracil (CEF) Compared With Standard CEF in Metastatic Breast Cancer Patients: Results of a Multicenter, Randomized Phase III Study of the Italian Gruppo Oncologico Nord-Ouest–Mammella Inter Gruppo Group
Accelerated-Intensified Cyclophosphamide, Epirubicin, and Fluorouracil (CEF) Compared With Standard CEF in Metastatic Breast Cancer Patients: Results of a Multicenter, Randomized Phase III Study of the Italian Gruppo Oncologico Nord-Ouest–Mammella Inter Gruppo Group
Material Type:
Artigo 		Adicionar ao Meu Espaço

Accelerated-Intensified Cyclophosphamide, Epirubicin, and Fluorouracil (CEF) Compared With Standard CEF in Metastatic Breast Cancer Patients: Results of a Multicenter, Randomized Phase III Study of the Italian Gruppo Oncologico Nord-Ouest–Mammella Inter Gruppo Group

DEL MASTRO, Lucia ; VENTURINI, Marco ; COMIS, Silvia ; ROSSO, Riccardo ; LIONETTO, Rita ; CARNINO, Flavio ; GUARNERI, Domenico ; GALLO, Luigi ; CONTU, Antonio ; PRONZATO, Paolo ; VESENTINI, Lorella ; BERGAGLIO, Marina

Journal of clinical oncology, 2001-04, Vol.19 (8), p.2213-2221 [Periódico revisado por pares]

Baltimore, MD: American Society of Clinical Oncology

Sem texto completo

Citações Citado por
9
Carboplatin, methotrexate, and vinblastine in the treatment of patients with advanced urothelial cancer. A phase II trial
Carboplatin, methotrexate, and vinblastine in the treatment of patients with advanced urothelial cancer. A phase II trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Carboplatin, methotrexate, and vinblastine in the treatment of patients with advanced urothelial cancer. A phase II trial

Boccardo, Francesco ; Pace, Maurizio ; Guarneri, Domenico ; Canobbio, Luciano ; Curotto, Antonio ; Martorana, Giuseppe

Cancer, 1994-04, Vol.73 (7), p.1932-1936 [Periódico revisado por pares]

New York: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
10
Paclitaxel plus ifosfamide in advanced ovarian cancer : A multicenter phase II study
Paclitaxel plus ifosfamide in advanced ovarian cancer : A multicenter phase II study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Paclitaxel plus ifosfamide in advanced ovarian cancer : A multicenter phase II study

MIGLIETTA, L ; AMOROSO, D ; MARTINI, M. C ; BREMA, F ; ADDAMO, G ; MORAGLIO, L ; PASTORINO, G ; BOCCARDO, F ; BRUZZONE, M ; GRANETTO, C ; CATSAFADOS, E ; MAMMOLITI, S ; GUARNERI, D ; PEDULLA, F ; FOGLIA, G ; RAGNI, N

Oncology, 1997-03, Vol.54 (2), p.102-107 [Periódico revisado por pares]

Basel: Karger

Sem texto completo

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Mostrar Somente

  1. Recursos Online (7)

Data de Publicação 

De até
Refinar
  1. Antes de1997  (2)
  2. 1997Até2004  (2)
  3. 2005Até2009  (2)
  4. 2010Até2019  (3)
  5. Após 2019  (2)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.